Company
United StatesGlycadia, Inc dba Exocell, Philadelphia, PA – FDA Inspections
Inspection records and compliance data for Glycadia, Inc dba Exocell in Philadelphia, Pennsylvania. 3 FDA inspections on record, last inspected September 29, 2015.
Company Profile
This profile covers Glycadia, Inc dba Exocell based in Philadelphia, Pennsylvania, United States.
FDA Inspection History
- FDA inspections
- 3
- OAI
- 0
- VAI
- 0
- NAI
- 3
- Form 483s
- 0
- Warning letters
- 0
First inspected August 7, 2009. Last inspected September 29, 2015.
FDA inspections (3)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| September 29, 2015 | NAI | Medical Devices & Rad Health · Postmarket Assurance: Devices | 945611 |
| September 6, 2012 | NAI | Medical Devices & Rad Health · Postmarket Assurance: Devices | 796446 |
| August 7, 2009 | NAI | Medical Devices & Rad Health · Postmarket Assurance: Devices | 608672 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Glycadia, Inc dba Exocell
FEI Number
2528952
Address
1880 John F Kennedy Blvd, Suite 200, Philadelphia, Pennsylvania 19103, United States
Country
United States
ID: 235ca52b-b72e-47dc-add4-4eb0c4a5df64